Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 183

1.

Determinants of immunological and virological responses to antiretroviral therapy amongst HIV-infected adults in central Argentina: negative influence of hepatitis C infection.

Farías AA, Kremer LE, Allende L, Díaz Mdel P, Pisano MB, Contigiani MS, Ré VE.

Trans R Soc Trop Med Hyg. 2013 Jul;107(7):432-7. doi: 10.1093/trstmh/trt043. Epub 2013 Jun 11.

PMID:
23761392
[PubMed - indexed for MEDLINE]
3.

High seroprevalence of HBV and HCV infection in HIV-infected adults in Kigali, Rwanda.

Rusine J, Ondoa P, Asiimwe-Kateera B, Boer KR, Uwimana JM, Mukabayire O, Zaaijer H, Mugabekazi J, Reiss P, van de Wijgert JH.

PLoS One. 2013 May 22;8(5):e63303. doi: 10.1371/journal.pone.0063303. Print 2013.

PMID:
23717409
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

The influence of HCV coinfection on clinical, immunological and virological responses to HAART in HIV-patients.

Carmo RA, Guimarães MD, Moura AS, Neiva AM, Versiani JB, Lima LV, Freitas LP, Rocha MO.

Braz J Infect Dis. 2008 Jun;12(3):173-9.

PMID:
18833399
[PubMed - indexed for MEDLINE]
Free Article
5.

Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.

Antonucci G, Girardi E, Cozzi-Lepri A, Capobianchi MR, De Luca A, Puoti M, Petrelli E, Carnevale G, Rizzardini G, Grossi PA, Viganò P, Moioli MC, Carletti F, Solmone M, Ippolito G, Monforte AD; HepaI.Co.N.A. Study Group; Italian Cohort Naive for Antiretrovirals Study Group.

Clin Infect Dis. 2005 Jun 15;40(12):e101-9. Epub 2005 May 5.

PMID:
15909251
[PubMed - indexed for MEDLINE]
Free Article
6.

Immune restoration in human immunodeficiency virus and hepatitis C virus coinfected patients after highly active antiretroviral therapy.

Antonello VS, Appel-da-Silva MC, Kliemann DA, Santos BR, Tovo CV.

Braz J Infect Dis. 2013 Sep-Oct;17(5):551-4. doi: 10.1016/j.bjid.2013.01.015. Epub 2013 Jul 4.

PMID:
23831277
[PubMed - indexed for MEDLINE]
Free Article
7.

Transient liver injury associated with the early recovery of HCV-specific T-cell responses and HCV rebound in HIV-1/HCV coinfected patients undergoing highly active antiretroviral therapy.

Kang F, Chen W, Zhang X, Nie W, Fu J, Xu X, Zhao P, Zhang X, Li W, Wang FS, Zhang Z, Zhao M.

J Acquir Immune Defic Syndr. 2013 Feb 1;62(2):135-42. doi: 10.1097/QAI.0b013e3182752d20.

PMID:
23075912
[PubMed - indexed for MEDLINE]
8.

Immunological and virological responses to highly active antiretroviral therapy in a non-clinical trial setting in a developing Caribbean country.

Kilaru KR, Kumar A, Sippy N, Carter AO, Roach TC.

HIV Med. 2006 Mar;7(2):99-104.

PMID:
16420254
[PubMed - indexed for MEDLINE]
9.

Effect of hepatitis C virus on immunological and virological responses in HIV-infected patients initiating highly active antiretroviral therapy: a meta-analysis.

Tsiara CG, Nikolopoulos GK, Dimou NL, Bagos PG, Saroglou G, Velonakis E, Hatzakis A.

J Viral Hepat. 2013 Oct;20(10):715-24. doi: 10.1111/jvh.12101. Epub 2013 May 3.

PMID:
24010646
[PubMed - indexed for MEDLINE]
10.

Hepatitis C virus coinfection and HIV load, CD4+ cell percentage, and clinical progression to AIDS or death among HIV-infected women: Women and Infants Transmission Study.

Hershow RC, O'Driscoll PT, Handelsman E, Pitt J, Hillyer G, Serchuck L, Lu M, Chen KT, Yawetz S, Pacheco S, Davenny K, Adeniyi-Jones S, Thomas DL.

Clin Infect Dis. 2005 Mar 15;40(6):859-67. Epub 2005 Feb 18.

PMID:
15736020
[PubMed - indexed for MEDLINE]
Free Article
11.

Sustained virological response after early antiviral treatment of acute hepatitis C virus and HIV coinfection.

Schulze Zur Wiesch J, Pieper D, Stahmer I, Eiermann T, Buggisch P, Lohse A, Hauber J, van Lunzen J.

Clin Infect Dis. 2009 Aug 1;49(3):466-72. doi: 10.1086/600399.

PMID:
19580412
[PubMed - indexed for MEDLINE]
Free Article
12.

Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy.

Sullivan PS, Hanson DL, Teshale EH, Wotring LL, Brooks JT.

AIDS. 2006 May 12;20(8):1171-9.

PMID:
16691069
[PubMed - indexed for MEDLINE]
13.

Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy.

Rockstroh JK, Mocroft A, Soriano V, Tural C, Losso MH, Horban A, Kirk O, Phillips A, Ledergerber B, Lundgren J; EuroSIDA Study Group.

J Infect Dis. 2005 Sep 15;192(6):992-1002. Epub 2005 Aug 11.

PMID:
16107951
[PubMed - indexed for MEDLINE]
Free Article
14.

Predicting the magnitude of short-term CD4+ T-cell recovery in HIV-infected patients during first-line highly active antiretroviral therapy.

Castagna A, Galli L, Torti C, D'Arminio Monforte A, Mussini C, Antinori A, Cozzi-Lepri A, Ladisa N, De Luca A, Seminari E, Gianotti N, Lazzarin A.

Antivir Ther. 2010;15(2):165-75. doi: 10.3851/IMP1513.

PMID:
20386071
[PubMed - indexed for MEDLINE]
15.

Impact of hepatitis C virus coinfection on response to highly active antiretroviral therapy and outcome in HIV-infected individuals: a nationwide cohort study.

Weis N, Lindhardt BO, Kronborg G, Hansen AB, Laursen AL, Christensen PB, Nielsen H, Moller A, Sorensen HT, Obel N.

Clin Infect Dis. 2006 May 15;42(10):1481-7. Epub 2006 Apr 12.

PMID:
16619163
[PubMed - indexed for MEDLINE]
Free Article
16.

Impaired recovery of CD4+ cell counts following highly active antiretroviral therapy in drug-naïve patients coinfected with human immunodeficiency virus and hepatitis C virus.

Macías J, Pineda JA, Lozano F, Corzo JE, Ramos A, León E, García-García JA, Fernández-Rivera J, Mira JA, Gómez-Mateos J.

Eur J Clin Microbiol Infect Dis. 2003 Nov;22(11):675-80. Epub 2003 Oct 23.

PMID:
14574616
[PubMed - indexed for MEDLINE]
17.

HIV/HBV and HIV/HCV coinfection, and outcomes following highly active antiretroviral therapy.

Lincoln D, Petoumenos K, Dore GJ; Australian HIV Observational Database.

HIV Med. 2003 Jul;4(3):241-9.

PMID:
12859323
[PubMed - indexed for MEDLINE]
18.

Hepatitis C infection on immune recovery in HIV-positive patients on successful HAART: the role of genotype 3.

Seminari E, Tinelli C, Ravasi G, Ripamonti D, Ladisa N, Marino N, Sighinolfi L, Mondello P, Migliorino M, Carosi G, Maserati R; MASTER Cohort.

Curr HIV Res. 2010 Apr;8(3):186-93.

PMID:
20163342
[PubMed - indexed for MEDLINE]
19.

HCV genotype distribution among HIV co-infected individuals in Argentina: relationship with host and viral factors.

Quarleri JF, Bolcic FM, Bouzas MB, Laufer N, Gómez Carrillo M, Mammana L, Kaufman S, Pérez H, Cahn P, Salomon H.

Acta Gastroenterol Latinoam. 2007 Jun;37(2):76-83.

PMID:
17684937
[PubMed - indexed for MEDLINE]
20.

Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects.

De Luca A, Bugarini R, Lepri AC, Puoti M, Girardi E, Antinori A, Poggio A, Pagano G, Tositti G, Cadeo G, Macor A, Toti M, D'Arminio Monforte A; Italian Cohort Naive Antiretrovirals Study Group.

Arch Intern Med. 2002 Oct 14;162(18):2125-32.

PMID:
12374521
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk